Eligibility for Anti-Obesity Medications Among Medicare Beneficiaries with Overweight or Obesity
J Gen Intern Med
.
2024 Oct 30.
doi: 10.1007/s11606-024-09178-8.
Online ahead of print.
Authors
Ashwin K Chetty
1
,
Mihir Khunte
2
,
Alissa S Chen
3
,
Ania M Jastreboff
4
,
Harlan M Krumholz
5
,
Yuan Lu
6
Affiliations
1
Yale School of Medicine, New Haven, CT, USA.
2
Warren Alpert Medical School of Brown University, Providence, RI, USA.
3
National Clinician Scholars Program, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
4
Yale Obesity Research Center (Y-Weight), Department of Internal Medicine (Endocrinology), Yale School of Medicine, New Haven, CT, USA.
5
Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, CT, USA.
6
Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, CT, USA. y.lu@yale.edu.
PMID:
39477867
DOI:
10.1007/s11606-024-09178-8
No abstract available
Publication types
Letter